Identification of new biomarkers for intestinal barrier functio
Not Applicable
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000039148
- Lead Sponsor
- Meiji Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 112
Inclusion Criteria
Not provided
Exclusion Criteria
1. History of gastrointestinal surgical procedures 2. Presence of galactosemia 3. Presence of diabetes 4. Presence of a allergy to food containing sugar alcohol 5. Subjects who routinely used pharmaceuticals 6. Pregnant women, lactating and possibly pregnant 7. Subjects who had participated in other clinical trials within the past month 8. Determined ineligible by the principal investigator or sub-investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To investigate the relationship between known biomarkers for intestinal barrier function and new biomarkers, such as novel compounds and intestinal microflora in biological samples, and to identify new biomarkers for intestinal barrier function.
- Secondary Outcome Measures
Name Time Method To investigate the relationship subjects background, such as physical examination, blood parameters, survey, and intestinal barrier function.